Implementation, availability and regulatory status of an OECD accepted Reconstructed Human Epidermis model in Brazil
2018
Vigil. sanit. debate 2018;6(1):64-71 | L'Oréal, EPISKIN
Safety Assessment of Botanicals: A Decision Tree Approach for the Safety Assessment of Botanical Cosmetic Ingredients
2012
SOT Society of Toxicology annual meeting | L'Oréal, Research & Innovation
Multiple Endpoint Analysis of the 3D-Reconstituted Corneal Epithelium after Treatment with Benzalkonium Chloride: Early Detection of Toxic Damage
2009
IOVS | VitroScreen, Milano, Italy
Multiple Endpoint Analysis of the 3D-Reconstituted Corneal Epithelium after Treatment with Benzalkonium Chloride: Early Detection of Toxic Damage
2009
lnvestigative Ophtalmology & Visual Science | Vitroscreen
Effects of Topically Applied Acitretin in Reconstructed Human Epidermis and the Rhino Mouse
2007
| SkinEthic
The use and interpretation of in vitro data in regulatory toxicology: cosmetics, toiletries and household products
2002
Toxicol Lett 2002 Feb 28 ;127 (1-3):177-82 | Health and Safety Executive, Magdalen House, Stanley Precinct, Bootle, Merseyside L20 3QZ, UK. [email protected]
13th Meeting of the Scientific Group on Methodologies for the Safety Evaluation of Chemicals (SGOMSEC): validation and acute toxicity testing
1998
Environ Health Perspect 1998 ;106 Suppl 2):419-25 |
Applications of reconstructed skin models in pharmaco-toxicological trials
1998
Med Biol Eng Comput 1998 ;36 (6):825-32 | Laboratoire des Substituts Cutanes (CNRS UPR 412), Hopital Edouard Herriot, Lyon, France. [email protected]
Applications of reconstructed skin models in pharmaco-toxicological trials
1998
Med Biol Eng Comput 1998 Nov ;36(6):825-832 | Laboratoire des Substituts Cutanes (CNRS UPR 412), Hopital Edouard Herriot, Lyon, France. [email protected]
Industry experience with alternative methods
1998
Toxicol Lett 1998 Dec 28 ;102-103):575-9 | Life Sciences-L'OREAL Advanced Research, Clichy, France.
Reconstructed skin for in vitro cutaneous pharmacotoxicology: Example of metabolic studies
1997
IN VITRO TOXICOL J MOL CELL TOXICOL. In Vitro Toxicology: Journal of Molecular and Cellular Toxicology 1997 ;10 (1):3-9 | R. Roguet, Life Sciences, L'Oreal Advanced Res. Laboratories, 1 Avenue E. Schueller, 93600 Aulnay sous Bois
Overview of in vitro cell culture technologies and pharmaco-toxicological applications
1997
Toxicology in vitro 1997 ;11 (5):591-599 | L'Oreal, Advanced Research, Life Sciences Research. I av. E. Schueller, 93601, Aulnay sous bois, France; Laboratoire de Cytophysiologie et Toxicologie Cellulaire, Universite Paris VII Denis Diderot, Tour 53/54 E3, 2 Place Jussieu, 75251 Paris, France; Sch
Cytokine mRNA expression in an in vitro human skin model, SKIN(2TM)
1996
Toxicology in Vitro 1996 ;10 (5):513-521 | E.E. Sikorski, The Procter and Gamble Co., Miami Valley Laboratory, PO Box 538707, Cincinnati, OH 45253-8707
Ex vivo reconstruction of the epidermis by melanocytes: Status of development and future perspectives
1996
Aktuelle Dermatologie 1996 ;22 (Suppl. 2):67-69 | Service de Dermatologie, Hopital Pellegrin Enfants, 168, Course de l'Argonne,F-33076 Bordeaux Cedex
Cytotoxicity testing using neutral red and MTT assays on a three-dimensional human skin substrate
1991
Toxicology in Vitro 1991 ;5 (5-6):573-578 | Marrow-Tech, Inc., 10933 No. Torrey Pines Road, La Jolla, CA 92037
Epidermis generated in vitro: Practical considerations and applications
1991
Journal of Cellular Biochemistry 1991 ;45 (3):245-251 | Organogenesis Inc., 83 Rogers Street,Cambridge, MA 02142
Characterization of skin reconstructed on a chitosan-cross-linked collagen-glycosaminoglycan matrix
1990
Skin Pharmacology 1990 ;3 (2):107-114 | Laboratoire de Substituts Cutanes (CNRS-URA 1341), Hopital Edouard Herriot, Pavillon 15, Place Arsonval, F-69437 Lyon
Reconstituted epidermis: a novel model for the study of drug metabolism in human epidermis
1990
J Invest Dermatol 1990 ;94 (6):749-52 | Centre du Medicament Nancy, France.
Reconstruction of the human skin equivalent in vitro: a new tool for skin biology
1990
Skin Pharmacol 1990 ;3 (2):144-8 | Laboratoire de Dermatologie, INSERM U, Hopital St. Louis, Paris, France.